Pharmacovigilance Blog

Our company

Designing and Implementing an Effective QMS

Designing and implementing an effective QMS is essential for ensuring consistency, compliance, and continuous improvement across any organization.

Bala

Read

Drug safety and pharmacovigilance

Subjects in Clinical Studies: Explained

In this comprehensive article, you’ll discover who the key term by subjects in clinical studies. Let’s dive in and explore.

Bala

Read

Drug safety and pharmacovigilance

Key Departments and Roles in Pharmacovigilance

This comprehensive article highlights the core departments that are essential for the smooth and effective functioning of a pharmacovigilance (PV) department.

Bala

Read

Drug safety and pharmacovigilance

Adverse Event Reporting: How to Do It Right

This article explains the importance of adverse event reporting to how to further process for effective submission reports to regulatory authorities.

Bala

Read

Exploring Adverse Events

Adverse Event Coding: Signs and Symptoms

This blog covers: Introduction Pharmacovigilance coding involves several complex and often confusing areas, including indications, adverse events, and…

Bala

Read

ICSR Management

Warnings and Precautions: Key Insights from Safety Documents

This article explores how the Warnings and Precautions section of safety documents plays a critical role in this process. Let’s dive in and explore.

Bala

Read

Who & When & How

PV Essentials: Product Specific Documents

This article would give you an insights product-specific documents and the Company Core Data Sheet (CCDS) are two essential yet often misunderstood references.

Bala

Read

ICSR Management

Condition aggravated: A scenario

Understanding how to handle condition aggravated as reported as an adverse event is a common challenge in pharmacovigilance case processing. Let’s dive in.

Bala

Read